REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ngd Pharma Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: All Other Food Manufacturing | Pharmaceutical Preparation Manufacturing | Toilet Preparation Manufacturing | Specialized Design Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | Educational Support Services
Full name: Ngd Pharma Sp. z o.o. Profile Updated: July 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Ngd Pharma Sp. z o.o. is based in Poland. The head office is in Bielany Wroclawskie. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was incorporated on April 24, 2019. Its’ total assets recorded a negative growth of 57.96%.

Headquarters
Ul. Wroclawska 44C
Bielany Wroclawskie; Dolnoslaskie; Postal Code: 55-040

Contact Details: Purchase the Ngd Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ngd Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Ngd Pharma Sp. z o.o. report to view the information.
Incorporation Date:
April 24, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ngd Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
7.45%▲
Operating profit (EBIT)
19.47%▲
EBITDA
N/A
Net Profit (Loss) for the Period
19.47%▲
Total assets
-57.96%▼
Total equity
-68.19%▼
Return on Equity (ROE)
-129.66%▼
Quick Ratio
-57.32%▼
Cash Ratio
-50.77%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo